These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 9403714)

  • 21. Tuberous sclerosis complex: Hamartin and tuberin expression in renal cysts and its discordant expression in renal neoplasms.
    Bonsib SM; Boils C; Gokden N; Grignon D; Gu X; Higgins JP; Leroy X; McKenney JK; Nasr SH; Phillips C; Sangoi AR; Wilson J; Zhang PL
    Pathol Res Pract; 2016 Nov; 212(11):972-979. PubMed ID: 27640314
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Renal angiomyolipomas from patients with sporadic lymphangiomyomatosis contain both neoplastic and non-neoplastic vascular structures.
    Karbowniczek M; Yu J; Henske EP
    Am J Pathol; 2003 Feb; 162(2):491-500. PubMed ID: 12547707
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Brain lesions in tuberous sclerosis complex. Review.
    Grajkowska W; Kotulska K; Jurkiewicz E; Matyja E
    Folia Neuropathol; 2010; 48(3):139-49. PubMed ID: 20924998
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Morphology of cerebral lesions in the Eker rat model of tuberous sclerosis.
    Wenzel HJ; Patel LS; Robbins CA; Emmi A; Yeung RS; Schwartzkroin PA
    Acta Neuropathol; 2004 Aug; 108(2):97-108. PubMed ID: 15185103
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reduction of expression of tuberin, the tuberous-sclerosis-complex-gene-2 product in tuberous sclerosis complex associated connective tissue nevi and sporadic squamous and basal cell carcinomas.
    Wienecke R; Klemm E; Karparti S; Swanson NA; Green AJ; DeClue JE
    J Cutan Pathol; 2002 May; 29(5):287-90. PubMed ID: 12100629
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The methylation of the TSC2 promoter underlies the abnormal growth of TSC2 angiomyolipoma-derived smooth muscle cells.
    Lesma E; Sirchia SM; Ancona S; Carelli S; Bosari S; Ghelma F; Montanari E; Di Giulio AM; Gorio A
    Am J Pathol; 2009 Jun; 174(6):2150-9. PubMed ID: 19443708
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Loss of expression of tuberin and hamartin in tuberous sclerosis complex-associated but not in sporadic angiofibromas.
    Fackler I; DeClue JE; Rust H; Vu PA; Kutzner H; Rütten A; Kaddu S; Sander CA; Volkenandt M; Johnson MW; Vinters HV; Wienecke R
    J Cutan Pathol; 2003 Mar; 30(3):174-7. PubMed ID: 12641776
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Multiple giant angiomyolipomas with a polygonal epithelioid cell component in tuberous sclerosis: an autopsy case report.
    Koide O; Matsuzaka K; Tanaka Y
    Pathol Int; 1998 Dec; 48(12):998-1002. PubMed ID: 9952347
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tuberous sclerosis complex-associated angiomyolipomas: focus on mTOR inhibition.
    Budde K; Gaedeke J
    Am J Kidney Dis; 2012 Feb; 59(2):276-83. PubMed ID: 22130643
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The role of tuberin in cellular differentiation: are B-Raf and MAPK involved?
    Karbowniczek M; Henske EP
    Ann N Y Acad Sci; 2005 Nov; 1059():168-73. PubMed ID: 16382052
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nox4 is a Target for Tuberin Deficiency Syndrome.
    Shi Q; Viswanadhapalli S; Friedrichs WE; Velagapudi C; Szyndralewiez C; Bansal S; Bhat MA; Choudhury GG; Abboud HE
    Sci Rep; 2018 Feb; 8(1):3781. PubMed ID: 29491408
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Therapeutic Targeting of the Secreted Lysophospholipase D Autotaxin Suppresses Tuberous Sclerosis Complex-Associated Tumorigenesis.
    Feng Y; Mischler WJ; Gurung AC; Kavanagh TR; Androsov G; Sadow PM; Herbert ZT; Priolo C
    Cancer Res; 2020 Jul; 80(13):2751-2763. PubMed ID: 32393662
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Renal disease in tuberous sclerosis complex: pathogenesis and therapy.
    Lam HC; Siroky BJ; Henske EP
    Nat Rev Nephrol; 2018 Nov; 14(11):704-716. PubMed ID: 30232410
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mutational analysis of the tuberous sclerosis gene TSC2 in patients with pulmonary lymphangioleiomyomatosis.
    Astrinidis A; Khare L; Carsillo T; Smolarek T; Au KS; Northrup H; Henske EP
    J Med Genet; 2000 Jan; 37(1):55-7. PubMed ID: 10633137
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chromosome 16 loss of heterozygosity in tuberous sclerosis and sporadic lymphangiomyomatosis.
    Yu J; Astrinidis A; Henske EP
    Am J Respir Crit Care Med; 2001 Oct; 164(8 Pt 1):1537-40. PubMed ID: 11704609
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expression of the tuberous sclerosis 2 gene product, tuberin, in adult and developing nervous system tissues.
    Geist RT; Reddy AJ; Zhang J; Gutmann DH
    Neurobiol Dis; 1996 Apr; 3(2):111-20. PubMed ID: 9173918
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Multicenter phase 2 trial of sirolimus for tuberous sclerosis: kidney angiomyolipomas and other tumors regress and VEGF- D levels decrease.
    Dabora SL; Franz DN; Ashwal S; Sagalowsky A; DiMario FJ; Miles D; Cutler D; Krueger D; Uppot RN; Rabenou R; Camposano S; Paolini J; Fennessy F; Lee N; Woodrum C; Manola J; Garber J; Thiele EA
    PLoS One; 2011; 6(9):e23379. PubMed ID: 21915260
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Abnormal cortical cells and astrocytomas in the Eker rat model of tuberous sclerosis complex.
    Takahashi DK; Dinday MT; Barbaro NM; Baraban SC
    Epilepsia; 2004 Dec; 45(12):1525-30. PubMed ID: 15571510
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Response to everolimus is seen in TSC-associated SEGAs and angiomyolipomas independent of mutation type and site in TSC1 and TSC2.
    Kwiatkowski DJ; Palmer MR; Jozwiak S; Bissler J; Franz D; Segal S; Chen D; Sampson JR
    Eur J Hum Genet; 2015 Dec; 23(12):1665-72. PubMed ID: 25782670
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Transgenic expression of dominant negative tuberin through a strong constitutive promoter results in a tissue-specific tuberous sclerosis phenotype in the skin and brain.
    Govindarajan B; Brat DJ; Csete M; Martin WD; Murad E; Litani K; Cohen C; Cerimele F; Nunnelley M; Lefkove B; Yamamoto T; Lee C; Arbiser JL
    J Biol Chem; 2005 Feb; 280(7):5870-4. PubMed ID: 15576369
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.